PharmiWeb1h
Pigmented Lesion Treatment Market to Reach USD 7,6…
Pigmented Lesion Treatment MarketThe pigmented lesion treatment market is set to expand from USD 3,591.3 million in 2023 to USD 7,614.7 million by 2033, growing at a CAGR of 7.8% over the forecast ...
PharmiWeb1h
Non-Surgical Fat Reduction Market to Reach USD 2,9…
Non-Surgical Fat Reduction MarketThe non-surgical fat reduction market is projected to grow at a CAGR of 5.6%, expanding from USD 1,700.5 million in 2024 to USD 2,932.3 million by 2034. This growth is ...
PharmiWeb1h
Travel Nurses, Inc. Named a Top Workplace by the Commercial Appeal for the Fourth Consecutive Year
The Commercial Appeal announced Travel Nurses, Inc. is a winner of the Memphis Metro Area Top Workplaces award for 2024 and 2025. GERMANTOWN, TENNESSEE / ACCESS Newswire / February 12, 2025 / Travel ...
PharmiWeb4h
Candid Health Raises $52.5 Million Series C to Enhance GenAI Features, Expand Revenue Cycle Automation Platform to More Providers
SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / February 12, 2025 / Candid Health, the autonomous revenue cycle automation platform for healthcare providers, today announced it has raised $52.5 million ...
PharmiWeb6h
3d Cell Culture Market: Comprehensive Analysis and Forecast (2025–2035)
The 3D cell culture industry is poised for substantial growth from 2025 to 2035, driven by advancements in biotechnology and ...
PharmiWeb6h
Healthcare Analytics Market Size/Growth 2025-2035
Market OverviewThe Global Healthcare Analytics Market is valued at $33.80 Billion in the year 2022 and is forecasted to reach ...
PharmiWeb6h
Generic Drugs Market 2024-2035: Trends, Innovations, and Future Growth
Market OverviewThe Global Generic Drugs Market was valued at $411.99 Billion in 2022 and is projected to reach $613.34 ...
PharmiWeb6h
Diabetes Drugs Market Forecasted to Reach US$ 177.74 Billion by 2034, Expanding at a CAGR of 7.7%
The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...
PharmiWeb6h
Precision Medicine Market Analysis & Forecast 2025-2035
Precision medicine is an innovative approach in healthcare that takes into account individual differences in genes, ...
PharmiWeb6h
Seaport Therapeutics Announces the Publication of…
Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the ...
PharmiWeb6h
OKYO Pharma Announces OK-101 Officially Assigned USAN : Urcosimod
OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...
PharmiWeb8h
Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status
CARDIFF, UK / ACCESS Newswire / February 12, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the ...